Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: a randomized, controlled study - study protocol

Paweł Bąkowski, Jakub Kaszyński, Joanna Wałecka, Kinga Ciemniewska-Gorzela, Kamilla Bąkowska-Żywicka, Tomasz Piontek, Paweł Bąkowski, Jakub Kaszyński, Joanna Wałecka, Kinga Ciemniewska-Gorzela, Kamilla Bąkowska-Żywicka, Tomasz Piontek

Abstract

Background: Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.

Methods: This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.

Discussion: This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.

Trial registration: name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.

Keywords: Autologous subcutaneous adipose tissue; Intra- articular injection; Knee OA; Platelet rich plasma.

Conflict of interest statement

Not applicable.

Figures

Fig. 1
Fig. 1
Study design

References

    1. Chahla J, Mandelbaum BR. Biological treatment for osteoarthritis of the knee: moving from bench to bedside-current practical concepts. Arthroscopy. 2018;34(5):1719–1729. doi: 10.1016/j.arthro.2018.01.048.
    1. Hermann W, Lambova S, Muller-Ladner U. Current treatment options for osteoarthritis. Curr Rheumatol Rev. 2018;14(2):108–116. doi: 10.2174/1573397113666170829155149.
    1. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N. Treatment of primary and secondary osteoarthritis of the knee. Evid Rep. Technol Assess (Full Rep). 2007;(157):1–157.
    1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–656.
    1. Hiligsmann M, Cooper C, Arden N, et al. Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO) Semin Arthritis Rheum. 2013;43(3):303–313. doi: 10.1016/j.semarthrit.2013.07.003.
    1. Bartholdy C, Juhl C, Christensen R, Lund H, Zhang W, Henriksen M. The role of muscle strengthening in exercise therapy for knee osteoarthritis: a systematic review and meta-regression analysis of randomized trials. Semin Arthritis Rheum. 2017;47(1):9–21. doi: 10.1016/j.semarthrit.2017.03.007.
    1. Bartels EM, Juhl CB, Christensen R, et al. Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Syst Rev. 2016;3:CD005523. doi: 10.1002/14651858.CD005523.pub3.
    1. Delanois RE, Etcheson JI, Sodhi N, et al. Biologic therapies for the treatment of knee osteoarthritis. J Arthroplast. 2019;34(4):801–813. doi: 10.1016/j.arth.2018.12.001.
    1. Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32(3):495–505. doi: 10.1016/j.arthro.2015.08.005.
    1. Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659–670.e1. doi: 10.1016/j.arthro.2016.09.024.
    1. Xing D, Wang B, Zhang W, et al. Intra-articular platelet-rich plasma injections for knee osteoarthritis: An overview of systematic reviews and risk of bias considerations. Int J Rheum Dis. 2017;20(11):1612–1630. doi: 10.1111/1756-185X.13233.
    1. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–364. doi: 10.1177/0363546512471299.
    1. Garay-Mendoza D, Villarreal-Martínez L, Garza-Bedolla A, et al. The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis. Int J Rheum Dis. 2018;21(1):140–147. doi: 10.1111/1756-185X.13139.
    1. Bianchi F, Maioli M, Leonardi E, et al. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013;22(11):2063–2077. doi: 10.3727/096368912X657855.
    1. Schiavone Panni A, Vasso M, Braile A, et al. Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop. 2019;43(1):7–13. doi: 10.1007/s00264-018-4182-6.
    1. Roos EM, Lohmander LS. The knee injury and osteoarthritis outcome score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64. doi: 10.1186/1477-7525-1-64.
    1. Paradowski PT, Kęska R, Witoński D. Validation of the polish version of the knee injury and osteoarthritis outcome score (KOOS) in patients with osteoarthritis undergoing total knee replacement. BMJ Open. 2015;5(7):e006947. doi: 10.1136/bmjopen-2014-006947.
    1. Paradowski PT, Witoński D, Kęska R, Roos EM. Cross-cultural translation and measurement properties of the polish version of the knee injury and osteoarthritis outcome score (KOOS) following anterior cruciate ligament reconstruction. Health Qual Life Outcomes. 2013;11:107. doi: 10.1186/1477-7525-11-107.
    1. Anderson AF, Irrgang JJ, Kocher MS, Mann BJ, Harrast JJ. International knee documentation committee. The international knee documentation committee subjective knee evaluation form: normative data. Am J Sports Med. 2006;34(1):128–135. doi: 10.1177/0363546505280214.
    1. Piontek T, Ciemniewska-Gorzela K, Naczk J, Cichy K, Szulc A. Linguistic and cultural adaptation into polish of the IKDC 2000 subjective knee evaluation form and the Lysholm scale. Pol Orthop Traumatol. 2012;77:115–119.
    1. Theiler R, Spielberger J, Bischoff HA, Bellamy N, Huber J, Kroesen S. Clinical evaluation of the WOMAC 3.0 OA index in numeric rating scale format using a computerized touch screen version. Osteoarthr Cartil. 2002;10(6):479–481. doi: 10.1053/joca.2002.0807.
    1. Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmood Z. Validation study of a computerized version of the Western Ontario and McMaster universities VA3.0 osteoarthritis index. J Rheumatol. 1997;24(12):2413–2415.
    1. Golicki Dominik, Niewada Maciej. EQ-5D-5L Polish population norms. Archives of Medical Science. 2017;1:191–200. doi: 10.5114/aoms.2015.52126.
    1. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Yeung TS, Wessel J, Stratford PW, MacDermid JC. The timed up and go test for use on an inpatient orthopaedic rehabilitation ward. J Orthop Sports Phys Ther. 2008;38(7):410–417. doi: 10.2519/jospt.2008.2657.
    1. Goldberg A, Chavis M, Watkins J, Wilson T. The five-times-sit-to-stand test: validity, reliability and detectable change in older females. Aging Clin Exp Res. 2012;24(4):339–344. doi: 10.1007/BF03325265.
    1. Fearon A, Neeman T, Smith P, Scarvell J, Cook J. Pain, not structural impairments may explain activity limitations in people with gluteal tendinopathy or hip osteoarthritis: a cross sectional study. Gait Posture. 2017;52:237–243. doi: 10.1016/j.gaitpost.2016.12.005.
    1. Roos Ewa M, Lohmander L Stefan. Health and Quality of Life Outcomes. 2003;1(1):64. doi: 10.1186/1477-7525-1-64.
    1. KOOS User’s Guide. 2003. . Accessed 18 May 2020.
    1. Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil. 2013;21(11):1627–1637. doi: 10.1016/j.joca.2013.07.017.
    1. Bennell KL, Hunter DJ, Paterson KL. Platelet-rich plasma for the Management of hip and Knee Osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24. doi: 10.1007/s11926-017-0652-x.
    1. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil. 2006;14(12):1272–1280. doi: 10.1016/j.joca.2006.05.008.
    1. Pereira RC, Scaranari M, Benelli R, et al. Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng Part A. 2013;19(11–12):1476–1488. doi: 10.1089/ten.TEA.2012.0225.
    1. Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis [published correction appears in am J sports med. 2017 Apr;45(5):NP10] Am J Sports Med. 2017;45(2):339–346. doi: 10.1177/0363546516665809.
    1. Anitua E, Sánchez M, Nurden AT, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 2007;46(12):1769–1772. doi: 10.1093/rheumatology/kem234.
    1. Di Y, Han C, Zhao L, Ren Y. Is local platelet-rich plasma injection clinically superior to hyaluronic acid for treatment of knee osteoarthritis? A systematic review of randomized controlled trials. Arthritis Res Ther. 2018;20(1):128. doi: 10.1186/s13075-018-1621-0.
    1. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–15. doi: 10.1016/j.stem.2011.06.008.
    1. Caplan AI. All MSCs are pericytes? Cell Stem Cell. 2008;3(3):229–230. doi: 10.1016/j.stem.2008.08.008.
    1. Caplan AI, Sorrell JM. The MSC curtain that stops the immune system. Immunol Lett. 2015;168(2):136–139. doi: 10.1016/j.imlet.2015.06.005.
    1. Koh YG, Kwon OR, Kim YS, Choi YJ, Tak DH. Adipose-derived Mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy. 2016;32(1):97–109. doi: 10.1016/j.arthro.2015.09.010.
    1. Nguyen PD, Tran TD, Nguyen HT, et al. Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis. Stem Cells Transl Med. 2017;6(1):187–195. doi: 10.5966/sctm.2016-0023.
    1. Pers YM, Rackwitz L, Ferreira R, et al. Adipose Mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med. 2016;5(7):847–856. doi: 10.5966/sctm.2015-0245.
    1. Kim YS, Choi YJ, Lee SW, et al. Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthr Cartil. 2016;24(2):237–245. doi: 10.1016/j.joca.2015.08.009.
    1. Cattaneo G, De Caro A, Napoli F, Chiapale D, Trada P, Camera A. Micro-fragmented adipose tissue injection associated with arthroscopic procedures in patients with symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2018;19(1):176. doi: 10.1186/s12891-018-2105-8.
    1. Roos EM, Toksvig-Larsen S. Knee injury and osteoarthritis outcome score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1:17. doi: 10.1186/1477-7525-1-17.
    1. Pintat J, Silvestre A, Magalon G, et al. Intra-articular injection of Mesenchymal stem cells and platelet-rich plasma to treat Patellofemoral osteoarthritis: preliminary results of a long-term pilot study. J Vasc Interv Radiol. 2017;28(12):1708–1713. doi: 10.1016/j.jvir.2017.08.004.
    1. Pak J, Chang JJ, Lee JH, Lee SH. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet Disord. 2013;14:337. doi: 10.1186/1471-2474-14-337.
    1. Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain Management of Osteoarthritis in the human knee joint. Aesthet Surg J. 2016;36(2):229–236. doi: 10.1093/asj/sjv135.
    1. Spasovski Duško, Spasovski Vesna, Baščarević Zoran, Stojiljković Maja, Vreća Miša, Anđelković Marina, Pavlović Sonja. Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis. The Journal of Gene Medicine. 2018;20(1):e3002. doi: 10.1002/jgm.3002.
    1. Jo CH, Chai JW, Jeong EC, et al. Intra-articular injection of Mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med. 2017;45(12):2774–2783. doi: 10.1177/0363546517716641.
    1. Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived Mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504–511. doi: 10.1002/sctm.18-0122.
    1. Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) 1999;38(9):870–877. doi: 10.1093/rheumatology/38.9.870.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren